When to contact your GP or diabetes team : Persistent vomiting preventing fluid intake Severe abdominal pain, especially if radiating to the back (possible pancreatitis) Right upper abdominal pain, fever or jaundice (possible gallbladder problems) Signs of dehydration (dark urine, dizziness, reduced urination) Unexplained hypoglycaemia if on combination therapy New or worsening visual symptoms (especially if you have diabetic retinopathy) Allergic reactions (rash, swelling, breathing difficulties) Most patients tolerate GLP-1 medications well once past the initial adjustment period
hypertension, type 2 DM, dyslipidemia) A meta-analysis of 22 trials involving over 17,000 patients determined that 50.2% and 17.5% of patients treated with GLP-1RAs (exenatide, semaglutide & liraglutide) experienced a weight loss of 5% and 10% compared to placebo, and that patients without type 2 diabetes achieved a significantly greater weight loss compared to those with diabetes (Vosoughi et al, 2022)
Already training consistently before starting: Patients at our clinic in Doral who see the strongest lean mass response to CJC-1295/Ipamorelin are those who were already training 3 or more times per week before their first injection
Presented for research literature review only Godek A et al
One half of a Hass avocado contains about 10.5 grams of fat, which is about 80% of its total calories
Therefore, through this article, we aim to provide informational awareness about GLP-1 drugs and their role in managing type 2 diabetes